Search clinical trials for: Tumor Lysis Syndrome (TLS)

Total 68757 results

Sanofi

Completed

Fasturtec TLS Treatment / Prophylysis

Tumor Lysis Syndrome

United States
Unity Health Toronto
Roche Pharma AG

Completed

Medical Education for Better Multiple Sclerosis Outcomes (EDUCAR MS)

Multiple Sclerosis

Chile, Argentina, Canada, Spain
Menarini Group

Terminated

Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults (FLORET)

Tumor Lysis Syndrome

Spain, Hungary, Italy, Bulgaria
M.D. Anderson Cancer Center
Sanofi

Completed

Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS

Lymphoma | Leukemia | Tumor Lysis Syndrome

United States
University Hospital, Strasbourg, France

Unknown

ACL Reconstruction With the TLS Technique

Joint Trauma
M.D. Anderson Cancer Center
Sanofi

Completed

Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2

Lymphoma | Leukemia

United States
Gustave Roussy, Cancer Campus, Grand Paris
Merck Sharp & Dohme LLC

Not yet recruiting

Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab (NeoSarc)

Cancer

France
University Hospital, Grenoble

Not yet recruiting

Overview of Telemedicine in Children With Type 1 Diabetes (TLS-DID)

Diabetes Mellitus, Type 1 | Telemedicine | Children, Only
Kessler Foundation
Kessler Institute for Rehabilitation

Recruiting

Exoskeleton and Spinal Cord Stimulation for SCI

Muscle Spasticity | Spinal Cord Injury | Ambulation Difficulty

United States
Transparency Life Sciences

Unknown

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

United States
Transparency Life Sciences

Unknown

Decentralized Dietary UC Pilot Trial

Colitis, Ulcerative

United States
ConvaTec Inc.

Completed

Observational Study to Investigate the Use of Sterilized Porcine Placental Tissue in the Treatment of Chronic VLU

Wound Heal | Ulcer Venous

United States
ConvaTec Inc.

Completed

Sterilised, Porcine Placental Tissue in the Treatment of Chronic Diabetic Foot Ulcers

Diabetic Foot Ulcer

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy

Breast Neoplasms

China
M.D. Anderson Cancer Center
Sanofi

Completed

Rasburicase in Patients at Risk for Tumor Lysis Syndrome

Tumor Lysis Syndrome

United States
AbbVie

Not yet recruiting

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia
Centre Hospitalier Sud Francilien

Completed

Study of the Effect of Telemedicine on Glycemic Control for Patients With Diabetes and Treated With Insulin (TLS-DIAB)

Diabetes

France
M.D. Anderson Cancer Center

Recruiting

Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Tumor Lysis Syndrome

United States
Celgene

Recruiting

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Lymphoma

Japan
AbbVie

Completed

A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)

United States
AstraZeneca

Terminated

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Lymphoma | Multiple Myeloma | Advanced Solid Tumors | Hematologic Malignancies

United States
University Hospital, Geneva

Active, not recruiting

A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma (FRILLY)

Aggressive B-Cell Non-Hodgkin Lymphoma

Switzerland
Celgene

Completed

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Multiple Myeloma

United States, Japan
Celgene

Completed

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

Myelodysplastic Syndromes | Multiple Myeloma

Japan
Celgene

Completed

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Multiple Myeloma

Japan
National Cancer Institute (NCI)

Completed

Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma

Lymphoma

United States
St. Jude Children's Research Hospital
Sanofi

Completed

Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients

Lymphoma | Leukemia | Hyperuricemia | Tumor Lysis Syndrome

United States
Menarini Group

Completed

Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies (FLORENCE)

Tumor Lysis Syndrome
Sanofi

Terminated

Elitek (Rasburicase) Immuno-Monitoring Study

Tumor Lysis Syndrome

United States
Sanofi

Completed

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

Cancer | Hyperuricemia | Tumor Lysis Syndrome

United States
Sanofi

Completed

Rasburicase in Tumor Lysis Syndrome

Hyperuricemia

Brazil
Sanofi

Completed

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Hyperuricemia | Tumor Lysis Syndrome | Tumors

United States
Sanofi

Completed

Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome

Hyperuricemia

Korea, Republic of
Acibadem University
Boston Children's Hospital; Ege University

Recruiting

PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry

PTEN Hamartoma Tumor Syndrome | Macrocephaly Autism Syndrome

Turkey
University Hospital, Basel, Switzerland

Not yet recruiting

61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)

Neuroendocrine Tumors

Switzerland
Assistance Publique - Hôpitaux de Paris
Centre Leon Berard; Institut National de la Santé Et de la Recherche Médicale... and other collaborators

Not yet recruiting

Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers (PGLEXPO2)

Environmental Exposure | SDH Gene Mutation | SDH-Related Familial Paraganglioma | SDHx-Related Syndromes

France
Children's Oncology Group

Not yet recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Stage I Kidney Wilms Tumor | Stage II Kidney Wilms Tumor | Stage III Kidney Wilms Tumor | Stage IV Kidney Wilms Tumor
Instituto de Investigación Biomédica de Salamanca
Carlos III Health Institute

Recruiting

Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL

Cutaneous T-Cell Lymphoma

Spain
University of Utah

Not yet recruiting

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma (NeoRelapse)

Melanoma

United States
Philogen S.p.A.

Not yet recruiting

A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence (GLIOSTELLA)

Glioblastoma

United States
Jagiellonian University

Recruiting

Activity of Chronic Inflammation in PCOS

Polycystic Ovary Syndrome

Poland
South Egypt Cancer Institute
Assiut University; Shefa Al-orman Children Cancer Hospital

Recruiting

Study of Wilms Tumors Among Patients of Shefa Al-Orman Children Cancer Hospital

Wilms Tumor

Egypt
Ryvu Therapeutics SA

Recruiting

Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML (RIVER-52)

Acute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome

Italy, Poland
Seoul National University Hospital
Samsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaborators

Recruiting

Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

Primary Aldosteronism | Cushing Syndrome | Pheochromocytoma | Adrenal Cortical Carcinoma | Adrenal Tumor

Korea, Republic of
National Cancer Institute (NCI)

Not yet recruiting

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

Neurofibromatosis 1 | Nerve Sheath Neoplasms

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Study of TQB3454 Tablets in Patients With Blood Tumors

Acute Myeloid Leukemia | Myelodysplastic Syndromes

China
Tampere University Hospital
Tampere University

Recruiting

Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)

Lynch Syndrome | Urothelial Carcinoma

Canada, Finland
Fudan University

Not yet recruiting

HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer

Pancreatic Cancer

China
Vivent Health
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV (SWISH)

Human Immunodeficiency Virus | Human Papilloma Virus

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

Pancreatic Cancer | Capecitabine | Radiotherapy | Envafolimab

China

Search clinical trials for: Tumor Lysis Syndrome (TLS)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations